Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Life Sciences Information Technology (IT) Market Size, Value And Growth Trajectory Through 2030
The life sciences information technology (IT) market has seen substantial expansion in recent years. Its valuation is predicted to climb from $29.14 billion in 2025 to $33.3 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to several factors, including the increasing generation of digital data in life sciences, the growing complexity of clinical trial management, the wider adoption of electronic laboratory systems, the development of bioinformatics research, and the escalating demands for regulatory data.
The life sciences information technology (IT) market is projected to experience substantial growth over the next few years. This market is anticipated to expand to $56.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.0%. The expected increase during this period stems from factors such as escalating investments in cloud-native life science IT, the rising embrace of AI-driven bioinformatics, the broadening of interoperable healthcare data platforms, an increasing need for real-time research collaboration tools, and a heightened emphasis on cybersecurity within life sciences. Additionally, key trends for the forecast period include a greater adoption of integrated life science IT platforms, an uptick in the utilization of cloud-based laboratory systems, the increasing implementation of bioinformatics solutions, the wider application of digital clinical trial management tools, and a sharpened focus on data security and compliance.
Get A Free Sample Report With In-Depth Market Insights:
Life Sciences Information Technology (IT) Market Growth Drivers: What’s Behind The Acceleration?
The growing occurrence of chronic illnesses is anticipated to boost the expansion of the life science information technology (IT) market in the future. These are enduring health conditions lasting for prolonged durations, frequently throughout an individual’s life, and progressing gradually; examples include diabetes, cardiovascular diseases, and chronic respiratory ailments. The widespread nature of chronic diseases stems from factors like an aging demographic, inactive routines, inadequate nutrition, a rise in obesity, and environmental influences. Life science IT plays a crucial role in managing chronic diseases by enabling thorough data handling, supporting customized treatment approaches, and enhancing patient oversight and results via sophisticated analytics and unified health information systems. For example, in January 2023, the National Center for Biotechnology Information (NCBI), identified as a US-based medicine library, projected that the population aged 50 and above afflicted with one or multiple chronic illnesses will see a 99.5% surge by 2050, climbing from 71.52 million in 2020 to 142.66 million. Consequently, the increasing prevalence of chronic diseases is a key factor propelling the expansion of the life science information technology (IT) market.
Life Sciences Information Technology (IT) Market Segments: Where Is Growth Concentrated?
The life sciences information technology (it) market covered in this report is segmented –
1) By Type: Software, Service
2) By Solution: Drug Discovery Informatics, Clinical Trial Management, Bioinformatics, Laboratory Information Management, Other Solutions
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research And Development Organizations, Other End Users
Subsegments:
1) By Software: Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Clinical Trial Management Systems (CTMS), Regulatory Compliance Software, Bioinformatics Software, Data Analytics And Visualization Tools, Pharmaceutical Manufacturing Software
2) By Service: Implementation And Integration Services, Consulting Services, Training And Education Services, Managed IT Services, Support And Maintenance Services, Data Management Services, Outsourcing Services, Validation Services, Cloud Computing Services
Life Sciences Information Technology (IT) Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies active in the life sciences information technology (IT) market are prioritizing the development of sophisticated solutions, such as cloud-native SaaS platforms, to provide scalable, cost-efficient, and compliant options that enhance collaboration, data integration, and the pace of innovation. A cloud-native SaaS platform is defined as software-as-a-service applications specifically engineered to run within cloud environments, leveraging cloud infrastructure for improved scalability, flexibility, and reliability. For instance, in June 2023, Revvity Inc., a biotechnology company based in the US, unveiled the Signals Research Suite. This cloud-native SaaS platform is crafted to improve scientific collaboration in both drug discovery and the development of specialty chemicals. The suite integrates applications like Signals Notebook, VitroVivo, and Inventa, delivering comprehensive support throughout the entire drug development journey, from early-stage research to in vitro testing and safety evaluations. The Signals Research Suite is distinguished by its scientifically intelligent, integrated software applications that fully endorse the Make-Test-Decide lifecycle. Key attributes include advanced analytics and visualizations driven by TIBCO Spotfire, seamless integration with the industry-standard ChemDraw, and a modern, streamlined interface that permits complete customization of workflows across various techniques, modalities, and datatypes. With secure single-sign-on access, consolidated data resources, helpful tutorials, and ongoing software updates, users can effectively focus on their experiments without the inconvenience of navigating disparate solutions.
Life Sciences Information Technology (IT) Market Key Participants And Competitive Landscape
Major companies operating in the life sciences information technology (it) market are Veeva Systems Inc., Medidata Solutions Inc., Oracle Corporation, SAP SE, International Business Machines Corporation, Microsoft Corporation, Accenture plc, Cognizant Technology Solutions Corporation, Dassault Systèmes SE, SAS Institute Inc., PTC Inc., Infor Inc., LabWare Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Certara Inc., IQVIA Holdings Inc., ArisGlobal LLC, Dotmatics Limited, Benchling Inc.
View The Full Life Sciences Information Technology (IT) Market Report:
Life Sciences Information Technology (IT) Market Top Region By Revenue And Market Share
North America was the largest region in the life sciences information technology (IT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life sciences information technology (it) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
